Efficacy and safety of vodobatinib in patients (pts) with chronic phase Philadelphia positive chronic myeloid leukemia (Ph + CML): A sub group analysis by lines of tyrosine kinase inhibitor (TKI) therapy Meeting Abstract
| Authors: | Cortes, J. E.; Saikia, T.; Kim, D. W.; Alvarado, Y.; Nicolini, F. E.; Rathnam, K.; Khattry, N.; Punatar, S.; Apperley, J. F.; Charbonnier, A.; Deininger, M.; de Lavallade, H.; Granacher, N.; Gambacorti-Passerini, C.; Lucchesi, A.; Mauro, M.; Vandenberghe, P.; Verhoef, G.; Whiteley, A. R.; Nag, A.; Apte, S.; Yao, S. L.; Inamdar, S.; Dillu, R. I.; Sreenivasan, J.; Chimote, G. |
| Abstract Title: | Efficacy and safety of vodobatinib in patients (pts) with chronic phase Philadelphia positive chronic myeloid leukemia (Ph + CML): A sub group analysis by lines of tyrosine kinase inhibitor (TKI) therapy |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 205 |
| End Page: | 207 |
| Language: | English |
| ACCESSION: | WOS:000893223200085 |
| DOI: | 10.1182/blood-2022-166452 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
